A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...
Start working toward program admission and requirements right away. Work you complete in the non-credit experience will transfer to the for-credit experience when you ...
ThatWare LLP, a globally recognized AI-powered digital marketing and search intelligence company, continues to push the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results